Polymer Capital Management (Hk) LTD Belite Bio, Inc Transaction History
Polymer Capital Management (Hk) LTD
- $725 Billion
- Q3 2025
A detailed history of Polymer Capital Management (Hk) LTD transactions in Belite Bio, Inc stock. As of the latest transaction made, Polymer Capital Management (Hk) LTD holds 7,266 shares of BLTE stock, worth $848,087. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,266Holding current value
$848,087% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding BLTE
# of Institutions
34Shares Held
2.28MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA875KShares$102 Million1.11% of portfolio
-
Rtw Investments, LP New York, NY313KShares$36.5 Million0.31% of portfolio
-
Vestal Point Capital, LP New York, NY313KShares$36.5 Million1.04% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT210KShares$24.5 Million0.94% of portfolio
-
Eventide Asset Management, LLC Boston, MA195KShares$22.8 Million0.27% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $2.9B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...